drugset / Trial / NCT01044199

Study of Intradermal Administration of PCEC Rabies Vaccine

NCT01044199 ↗

Non-randomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to determine immunogenicity and safety of intradermal administration of the PCEC rabies vaccine in adults.

Timeline

Start
2009-02
Primary completion
2009-09
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject PCEC rabies vaccine Vaccine 0.1 ml Intravitreal
Subject PCEC rabies vaccine Vaccine 1 ml Intravitreal

Indications